P/E at 64.61 vs Industry's 63.33: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium P/E in a Competitive Sector

Apollo Hospitals Enterprise Ltd. trades at a P/E of 64.61, slightly above the hospital industry’s average of 63.33. This premium, though not extreme, suggests investors are willing to pay more for the company’s earnings relative to its peers. The sector itself commands elevated valuations, reflecting growth expectations and the defensive nature of healthcare services. However, the premium also raises questions about whether the stock’s price fully discounts its current fundamentals or anticipates superior future performance — previously rated Hold, what is Apollo Hospitals’ current rating? The P/E differential is a key metric for investors weighing valuation against operational execution.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Stability

The stock’s performance over various timeframes highlights its resilience and growth trajectory. Over one year, Apollo Hospitals has gained 22.50%, a stark contrast to the Sensex’s 6.12% decline. This outperformance extends to longer horizons: a three-year return of 71.09% and a five-year surge of 135.41% underscore sustained value creation. Even the decade-long return of 544.65% dwarfs the Sensex’s 176.35%, illustrating the company’s robust growth over time.

Shorter-term returns also show positive momentum. The three-month gain of 17.62% outstrips the Sensex’s modest 0.48% rise, while the year-to-date return of 25.51% again beats the broader market’s 9.39% decline. Daily and weekly performances are more muted but remain positive, with a 0.70% gain today and a 0.06% increase over the past week. This steady appreciation — is this a sign of sustained strength or a pause before a new trend? — reflects investor confidence amid sector volatility.

Moving Average Configuration: A Bullish Medium-Term Setup with Short-Term Caution

The technical picture for Apollo Hospitals reveals a nuanced trend. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a solid medium- to long-term uptrend. However, it remains below the 5-day moving average, indicating some short-term consolidation or minor pullback. This configuration suggests the stock is in a recovery phase after a brief correction, with the longer-term trend intact but short-term momentum requiring confirmation — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry’s Mixed Performance

The hospital sector, to which Apollo Hospitals belongs, has shown a mixed performance profile recently. While some companies have struggled with margin pressures and regulatory challenges, others have benefited from increased healthcare demand and operational efficiencies. The sector’s average P/E of 63.33 reflects investor optimism tempered by these headwinds. Within this environment, Apollo Hospitals stands out for its consistent earnings growth and market leadership, which supports its valuation premium. Yet, the sector’s uneven results raise the question — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Hold, reflecting a reassessment of its fundamentals and technicals. The company’s Mojo Score stands at 75.0, indicating a strong overall profile. This change aligns with the stock’s robust long-term performance and its valuation standing relative to the sector. The rating update invites investors to reanalyse the stock’s position within their portfolios — what is the current rating?

Market Capitalisation and Price Levels

With a market capitalisation of approximately ₹1,27,097.73 crore, Apollo Hospitals is firmly established as a large-cap stock. The share price is currently trading close to its 52-week high, just 1.8% shy of the peak of ₹8,948.1. This proximity to the high suggests sustained investor interest and confidence in the company’s growth prospects. The stock’s recent trading range has been stable, opening at ₹8,790.2 and maintaining that level throughout the day, reflecting a consolidation phase after a two-day dip. The 0.70% gain today aligns with sector performance, indicating steady demand.

Consecutive Gain/Loss Streak and Momentum

After experiencing two consecutive days of decline, Apollo Hospitals has resumed upward movement, signalling a potential trend reversal. The stock’s position above key moving averages except the 5-day suggests that short-term momentum is still catching up with the broader positive trend. This pattern often precedes renewed buying interest, but the short-term caution remains visible in the technical setup — is this a recovery or a dead-cat bounce?

Collective Data Insights: Valuation, Performance, and Technicals

The data collectively paints a picture of a company trading at a slight valuation premium within a sector that commands elevated multiples. Its long-term performance is impressive, with returns well above the Sensex across multiple horizons, while short-term momentum shows signs of consolidation but remains positive overall. The moving average configuration supports a medium- to long-term uptrend, tempered by short-term caution. The recent rating reassessment from Hold to a stronger stance reflects these dynamics, inviting investors to reconsider the stock’s role in their portfolios.

Given these factors, Apollo Hospitals Enterprise Ltd. remains a compelling subject for analysis — should investors in Apollo Hospitals hold, buy more, or reconsider?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →